[1] CHEN W Q, ZHENG R S, BAADE P D, et al. Cancer statistics in China, 2015[J]. CA:Cancer J Clin, 2016, 66(2):115-132. [2] 王锦州.胃腺癌组织差异表达蛋白质的分离与鉴定[D].福州:福建医科大学,2013. [3] DEMMER J, ZHOU C, HUBBARD M J. Molecular cloning of ERp29, a novel and widely expressed resident of the endoplasmic reticulum[J]. FEBS Lett, 1997, 402(2/3):145-150. [4] MKRTCHIAN S, SANDALOVA T. ERp29, an unusual redox-inactive member of the thioredoxin family[J]. Antioxid Redox Signal, 2006, 8(3/4):325-337. [5] LIEPINSH E, BARYSHEV M, SHARIPO A, et al. Thioredoxin fold as homodimerization module in the putative chaperone ERp29:NMR structures of the domains and experimental model of the 51 kDa dimer[J]. Structure, 2001, 9(6):457-471. [6] CHERETIS C, DIETRICH F, CHATZISTAMOU I, et al. Expression of ERp29, an endoplasmic reticulum secretion factor in basal-cell carcinoma[J]. Am J Dermatopathol, 2006, 28(5):410-412. [7] FAN N J, GAO J L, LIU Y, et al. Label-free quantitative mass spectrometry reveals a panel of differentially expressed proteins in colorectal cancer[J]. Biomed Res Int, 2015,2015:365068. [8] DENG Y J, TANG N, LIU C, et al. CLIC4, ERp29, and Smac/DIABLO derived from metastatic cancer stem-like cells stratify prognostic risks of colorectal cancer[J]. Clin Cancer Res, 2014, 20(14):3809-3817. [9] SHNYDER S D, MANGUM J E, HUBBARD M J. Triplex profiling of functionally distinct chaperones (ERp29/PDI/BiP) reveals marked heterogeneity of the endoplasmic reticulum proteome in cancer[J]. J Proteome Res, 2008, 7(8):3364-3372. [10] ZHANG K, YAO H P, YANG Z, et al. Comparison of ILK and ERP29 expressions in benign and malignant pancreatic lesions and their clinicopathological significances in pancreatic ductal adenocarcinomas[J]. Clin Transl Oncol, 2016, 18(4):352-359. [11] BAMBANG I F, LU D, LI H P, et al. Cytokeratin 19 regulates endoplasmic reticulum stress and inhibits ERp29 expression via p38 MAPK/XBP-1 signaling in breast cancer cells[J]. Exp Cell Res, 2009, 315(11):1964-1974. [12] YUAN L W, LIU D C, YANG Z L. Correlation of S1P1 and ERp29 expression to progression, metastasis, and poor prognosis of gallbladder adenocarcinoma[J]. HBPD Int, 2013, 12(2):189-195. [13] BAMBANG I F, XU S C, ZHOU J B, et al. Overexpression of endoplasmic reticulum protein 29 regulates mesenchymal-epithelial transition and suppresses xenograft tumor growth of invasive breast cancer cells[J]. Lab Invest, 2009, 89(11):1229-1242. [14] WU J, YANG Y Y, GAO S S, et al. ERp29 inhibits tumorigenicity by suppressing epithelial mesenchymal transition in gastric cancer[J]. Oncotarget, 2017, 8(45):78757-78766. [15] ZHANG Y, HU Y, WANG J L, et al. Proteomic identification of ERP29 as a key chemoresistant factor activated by the aggregating p53 mutant Arg282Trp[J]. Oncogene, 2017, 36(39):5473-5483. [16] 钟文进.组织芯片研究ERp29在胃癌中的表达及意义[D].福州:福建医科大学,2014. |